The Parkinson's disease drug entacapone disrupts gut microbiome homoeostasis via iron sequestration/Experiment 3/Signature 1

From BugSigDB
Needs review

Curated date: 2024/11/21

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Supplementary Table 5

Description: Differential abundance of taxa between the drug-amendment experiments(ENT-High, ENT-Low, LOX-High and LOX-Low) after 24hrs of incubation.

Abundance in Group 1: increased abundance in Entacapone Low Concentration(ENT-Low) after 24 hrs of incubation

NCBI Quality ControlLinks
Colidextribacter
Butyricicoccaceae UCG-009Butyricicoccaceae UCG-009
unclassified Eggerthellaceae
Eubacterium coprostanoligenes
Unclassified Clostridia vadinBB60 groupUnclassified Clostridia vadinBB60 group
uncultured Oscillospiraceae bacterium
Unclassified Oscillospiraceae UCG-010Unclassified Oscillospiraceae UCG-010
unclassified Flavobacteriales

Revision editor(s): KateRasheed